Nosocomial Bloodstream Infection in a Pediatric Intensive Care Unit
Overview
Affiliations
Objective: To study the incidence of nosocomial blood stream infections (BSI) in a pediatric intensive care unit (PICU) of a tertiary care teaching hospital, identify the organisms responsible and the pattern of antibiotic resistance over one decade.
Methods: Data was retrieved from the records of PICU and Medical Microbiology laboratory of patients with a positive blood culture after 48 hours of admission to PICU over three time periods viz. 1994-1996, 1999-2001 and 2002-2003. Antibiotic sensitivity pattern was also analyzed.
Results: 861 episodes (1994-1996: 282, 1999-2001: 362 and 2002-2003: 217) of nosocomial bloodstream infection were documented in 841 patients, corresponding to 3.63, 5.94 and 4.99 episodes per 100 patient-days, respectively. Gram negative organisms were the predominant isolates; common being Klebsiella pneumoniae (20.1%), Enterobacter species (16.6%) and Acinetobacter species (8.6%). Staphylococcus aureus (16.4%) and yeast species (15.9%) were the major Gram positive isolates. Isolation of Staphylococcus aureus , Klebsiella and Acinetobacter species showed a rising trend while yeast (36.9%, 6.6% and 4.1%) showed a decline over the three time periods studied. An increasing trend of resistance to third generation cephalosporins, aminoglycosides, ciprofloxacin and newer antibiotics including combination of beta-lactam with beta-lactamase inhibitor was noted.
Conclusion: The predominant organisms responsible for nosocomial infection in the PICU were Klebsiella pneumoniae , Staphylococcus aureus and Enterobacter species . At present, carbapenems plus vancomycin appear to be the best choice for empiric antibiotic therapy in the PICU in Chandigarh.
Almazeedi M, Al Ghadeer H, Bugshan A, Alhrthi H, Alshuaibi M, Albarqi H Cureus. 2023; 15(10):e47561.
PMID: 38021580 PMC: 10666072. DOI: 10.7759/cureus.47561.
Duan N, Sun L, Huang C, Li H, Cheng B Front Microbiol. 2021; 12:792282.
PMID: 34956159 PMC: 8696172. DOI: 10.3389/fmicb.2021.792282.
Probiotic Bacterial Application in Pediatric Critical Illness as Coadjuvants of Therapy.
Zanza C, Romenskaya T, Longhitano Y, Piccolella F, Racca F, Tassi M Medicina (Kaunas). 2021; 57(8).
PMID: 34440989 PMC: 8399162. DOI: 10.3390/medicina57080781.
Pediatric Blood Cultures and Antibiotic Resistance: An Overview.
Wattal C, Goel N Indian J Pediatr. 2019; 87(2):125-131.
PMID: 31863394 PMC: 6974494. DOI: 10.1007/s12098-019-03123-y.
What's new in PICU in resource limited settings?.
Argent A, Chisti M, Ranjit S Intensive Care Med. 2017; 44(4):467-469.
PMID: 28913544 DOI: 10.1007/s00134-017-4905-y.